TANG KEVIN
SEC CIK 1178579 · EDGAR
BoughtSold
Most active insiders at BOLD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | 10% | $1.52M | $54.4K |
| 2 | ARCH Venture Fund IX, L.P. | 10% | — | $39.8K |
| 3 | CRANDELL KEITH | 10% | — | $39.8K |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-28 16:16 | 2026-08-26 | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10% | S - Sale | $2.97 | -18.3K | 2.84M | -0.6% | -$54.4K |
| MI | 2026-07-21 19:38 | 2026-07-17+ | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10% | P - Purchase | $2.44 | +4,863 | 2.86M | +0.2% | +$11.9K |
| MI | 2026-07-20 21:10 | 2026-07-16+ | FULC | Fulcrum Therapeutics, Inc. | TANG KEVIN | 10% | P - Purchase | $3.55 | +167.6K | 7.08M | +2% | +$594.7K |
| MI | 2026-07-16 20:10 | 2026-07-14+ | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10% | P - Purchase | $2.43 | +64.0K | 2.85M | +2% | +$155.6K |
| MI | 2026-07-15 19:50 | 2026-07-13+ | FULC | Fulcrum Therapeutics, Inc. | TANG KEVIN | 10% | P - Purchase | $3.57 | +249.9K | 6.91M | +4% | +$891.1K |
| MI | 2026-07-13 19:06 | 2026-07-09+ | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10% | P - Purchase | $2.42 | +91.6K | 2.79M | +3% | +$222.1K |
| MI | 2026-07-08 20:06 | 2026-07-06+ | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10% | P - Purchase | $2.48 | +57.2K | 2.70M | +2% | +$141.9K |
| MI | 2026-07-02 19:45 | 2026-06-30+ | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10% | P - Purchase | $2.50 | +107.5K | 2.64M | +4% | +$268.9K |
| MI | 2026-06-29 19:56 | 2026-06-25+ | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10% | P - Purchase | $2.50 | +286.3K | 2.53M | +13% | +$714.8K |
| DMI | 2026-06-02 21:54 | 2026-05-29+ | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | CEO, Dir, 10% | P - Purchase | $15.29 | +814.6K | 13.04M | +7% | +$12.46M |
| MI | 2026-03-03 | 2026-02-27+ | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Dir | P - Purchase | $14.10 | +900.0K | 11.63M | +8% | +$12.69M |
| MI | 2025-08-05 | 2025-08-01+ | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Dir | P - Purchase | $10.45 | +1.30M | 11.13M | +13% | +$13.59M |
| MI | 2025-03-04 | 2025-02-28+ | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Dir | P - Purchase | $7.95 | +1.60M | 9.28M | +21% | +$12.71M |
| MI | 2024-12-09 | 2024-12-05+ | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Dir | P - Purchase | $9.02 | +1.20M | 8.43M | +17% | +$10.82M |
Purchase Sale Sale after option exercise All abbreviations